Nuvation

My experience has been exceptional. I believe the RSU’s will be robust by the time offer letters go out. The science is superb and the leadership I’ve interacted with has been nothing but professional. Good luck to those moving forward. My experience is if I don’t hear from interviewing manager, it’s ok….. thanks for the opportunity and I move on. Good luck everyone who wants to be a part of this company. O
 






My experience has been exceptional. I believe the RSU’s will be robust by the time offer letters go out. The science is superb and the leadership I’ve interacted with has been nothing but professional. Good luck to those moving forward. My experience is if I don’t hear from interviewing manager, it’s ok….. thanks for the opportunity and I move on. Good luck everyone who wants to be a part of this company. O
Written by Nuvation manager
 












My experience has been exceptional. I believe the RSU’s will be robust by the time offer letters go out. The science is superb and the leadership I’ve interacted with has been nothing but professional. Good luck to those moving forward. My experience is if I don’t hear from interviewing manager, it’s ok….. thanks for the opportunity and I move on. Good luck everyone who wants to be a part of this company. O
I interviewed for the Denver role. Really enjoyed both hiring managers. They are competent and good leaders. Hiring manager called personally today to say they chose another candidate. I respect that immensely. I wish them well. A lot of recruiters and hiring managers could take note. A quick call is classy and used to be the norm, not the exception. Good luck commercializing Nuvation.
 












So far pretty professional, but there sales expectations are just incredible and the hiring time line is extremely short and not flexible to those who who are actual working. What up with the stock it dropping 90 days from approval?
 






They are hiring all their buddies from Mirati...Thats where the leadership team is from. Not very exciting being the 4th to market anyways.
Read the study, it is almost 25-30% better ORR and has 50% of patient still responding 44 months out nearly double competition and safety profile is cleaner…